| Product Code: ETC7328752 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ghana Hemophilia A Treatment Market Overview |
3.1 Ghana Country Macro Economic Indicators |
3.2 Ghana Hemophilia A Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 Ghana Hemophilia A Treatment Market - Industry Life Cycle |
3.4 Ghana Hemophilia A Treatment Market - Porter's Five Forces |
3.5 Ghana Hemophilia A Treatment Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Ghana Hemophilia A Treatment Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.7 Ghana Hemophilia A Treatment Market Revenues & Volume Share, By Demographic, 2021 & 2031F |
3.8 Ghana Hemophilia A Treatment Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.9 Ghana Hemophilia A Treatment Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.10 Ghana Hemophilia A Treatment Market Revenues & Volume Share, By Therapy, 2021 & 2031F |
4 Ghana Hemophilia A Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about hemophilia A and its treatment options in Ghana |
4.2.2 Growing healthcare infrastructure and access to specialized treatment centers in the country |
4.2.3 Rising incidence of hemophilia A cases in Ghana due to improved diagnosis and reporting |
4.3 Market Restraints |
4.3.1 Limited availability of advanced treatment options and therapies for hemophilia A in Ghana |
4.3.2 High cost associated with hemophilia A treatment, leading to affordability issues for patients |
4.3.3 Lack of skilled healthcare professionals and specialists in hemophilia treatment in Ghana |
5 Ghana Hemophilia A Treatment Market Trends |
6 Ghana Hemophilia A Treatment Market, By Types |
6.1 Ghana Hemophilia A Treatment Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Ghana Hemophilia A Treatment Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Ghana Hemophilia A Treatment Market Revenues & Volume, By Severe, 2021- 2031F |
6.1.4 Ghana Hemophilia A Treatment Market Revenues & Volume, By Moderate, 2021- 2031F |
6.1.5 Ghana Hemophilia A Treatment Market Revenues & Volume, By Mild, 2021- 2031F |
6.2 Ghana Hemophilia A Treatment Market, By Product |
6.2.1 Overview and Analysis |
6.2.2 Ghana Hemophilia A Treatment Market Revenues & Volume, By Recombinant Factor Concentrates, 2021- 2031F |
6.2.3 Ghana Hemophilia A Treatment Market Revenues & Volume, By Plasma-derived Factor Concentrates, 2021- 2031F |
6.2.4 Ghana Hemophilia A Treatment Market Revenues & Volume, By Extended Half-life Products, 2021- 2031F |
6.3 Ghana Hemophilia A Treatment Market, By Demographic |
6.3.1 Overview and Analysis |
6.3.2 Ghana Hemophilia A Treatment Market Revenues & Volume, By Pediatric, 2021- 2031F |
6.3.3 Ghana Hemophilia A Treatment Market Revenues & Volume, By Adult, 2021- 2031F |
6.4 Ghana Hemophilia A Treatment Market, By Diagnosis |
6.4.1 Overview and Analysis |
6.4.2 Ghana Hemophilia A Treatment Market Revenues & Volume, By Genetic Testing, 2021- 2031F |
6.4.3 Ghana Hemophilia A Treatment Market Revenues & Volume, By Fibrinogen Test, 2021- 2031F |
6.4.4 Ghana Hemophilia A Treatment Market Revenues & Volume, By Factor VIII and Factor IX Tests, 2021- 2031F |
6.4.5 Ghana Hemophilia A Treatment Market Revenues & Volume, By Prothrombin Time (PT), 2021- 2031F |
6.4.6 Ghana Hemophilia A Treatment Market Revenues & Volume, By Complete Blood Count (CBC), 2021- 2031F |
6.5 Ghana Hemophilia A Treatment Market, By Treatment |
6.5.1 Overview and Analysis |
6.5.2 Ghana Hemophilia A Treatment Market Revenues & Volume, By Prophylaxis, 2021- 2031F |
6.5.3 Ghana Hemophilia A Treatment Market Revenues & Volume, By On Demand, 2021- 2031F |
6.6 Ghana Hemophilia A Treatment Market, By Therapy |
6.6.1 Overview and Analysis |
6.6.2 Ghana Hemophilia A Treatment Market Revenues & Volume, By Factor Replacement Therapy, 2021- 2031F |
6.6.3 Ghana Hemophilia A Treatment Market Revenues & Volume, By Non-factor Replacement Therapy, 2021- 2031F |
7 Ghana Hemophilia A Treatment Market Import-Export Trade Statistics |
7.1 Ghana Hemophilia A Treatment Market Export to Major Countries |
7.2 Ghana Hemophilia A Treatment Market Imports from Major Countries |
8 Ghana Hemophilia A Treatment Market Key Performance Indicators |
8.1 Number of hemophilia treatment centers established in Ghana |
8.2 Percentage increase in hemophilia A patient diagnosis rates annually |
8.3 Average time taken from diagnosis to treatment initiation for hemophilia A patients in Ghana |
9 Ghana Hemophilia A Treatment Market - Opportunity Assessment |
9.1 Ghana Hemophilia A Treatment Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Ghana Hemophilia A Treatment Market Opportunity Assessment, By Product, 2021 & 2031F |
9.3 Ghana Hemophilia A Treatment Market Opportunity Assessment, By Demographic, 2021 & 2031F |
9.4 Ghana Hemophilia A Treatment Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.5 Ghana Hemophilia A Treatment Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.6 Ghana Hemophilia A Treatment Market Opportunity Assessment, By Therapy, 2021 & 2031F |
10 Ghana Hemophilia A Treatment Market - Competitive Landscape |
10.1 Ghana Hemophilia A Treatment Market Revenue Share, By Companies, 2024 |
10.2 Ghana Hemophilia A Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |